Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model

International Journal of Pharmaceutics 2026 Open access

Read full text
Authors: Melih Z. Kaya, Yakup Gültekin, M. Çelebier, Murat Soyseven, İmran Vural, Levent Öner, Ayata Cenk, Sibel Bozdağ Pehlivan, Andrea M. Harriott
DOI: 10.1016/j.ijpharm.2026.126743
Cited by: 1
References: 113

Fields of Study & Subjects

Migraine and Headache Studies Advanced Drug Delivery Systems Nanoplatforms for cancer theranostics

Publication details

Journal / source
International Journal of Pharmaceutics
Publisher
Elsevier BV
Volume
694
Pages
126743–126743
Publication date
5 March 2026
Language
EN